Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
possible
Gonna have some profit taking . If this is for real it will recover
or it is bigger news..idk
As of this point nothing else explains it
wonder if that report due by 15th is coming sooner
Nothing on edgar. Wonder what is up.
Settled convertible notes
8k out
come on, let's at least settle green
It could be more of a Due Diligence action
Due diligence is the investigation or exercise of care that a reasonable business or person is normally expected to take before entering into an agreement or contract with another party or an act with a certain standard of care.
or
business : research and analysis of a company or organization done in preparation for a business transaction (such as a corporate merger or purchase of securities)
Bio's of those at BRG https://biotechresearchgroup.com/about-us/#
Familiar with SoW from bidding on NFL synthetic turf projects when I was corporate. Detailed and exact, should have schedule chart as well
Thanks for info
On October 18, 2021 Regen Biopharma, Inc. (“Company”) has provided a Scope of Work order to Biotech Research Group directing Biotech Research Group to perform an independent assessment of work conducted to date on behalf of the Company by the Company’s Contract Research Organization in order to assist the Company in determining what would be the most efficient actions to undertake in order to commercialize the Company’s NR2F6 intellectual property as well as assist the Company with regulatory strategy with regard to the Company’s NR2F6 intellectual property . Total consideration to be paid by the Company to Biotech Research Group for providing these services is $25,000. The termination date of this Scope of Work Order is November 15, 2021.
8k out
Northern Illinois
Thanks. I agree and like I said I think this is the 3rd report we have seen with RGBP and three different groups of big pharma.
In it to win it.
And that's a problem, sheesh, lol
My chrome had a translator at bottom.
If it was already posted back then, then my apologies. I dont want to recirculate.
If noone did, then to this board its fresh, lol. Whatever
"We are in another group of some big pharma"
We must have some "goodies" to be in these different/separate research outlook reports. Not the bs pushed by certain stock sites that make the rounds.
Imo.
1)Someone was bored with old articles, this is a day old
2)We are in another group of some big pharma
Scroll... Table of contents 6.14, there we are!
Says its from a day ago...
https://zhuanlan.zhihu.com/p/420965534
Wonder if there will be another big volume purchase/sale that seems to come around this time
Ive seen that Vicky Klepsch involved in a lot of research regarding NR2F6. Highly respected.
Thinking some kind of news will be out this week. Nothing big but its been a while.
Have had a shit-ton of down days, time to head the other way.
https://www.wsj.com/market-data/quotes/TSOI/company-people/executive-profile/86388211
If it isnt the guy from Lilly that I posted,
maybe this guy could be a choice for cso. Lots of intertwining in the biotech industry
Not a lot of volume behind the pop
Yep just noticed, nice pop
Agreed
kinda agree with you. mm's drive it down chemdiv gets cheapies
Still on my chart/screen also
Again, well said Jack. I'm in line with your thoughts.
Are you or any other charters seeing on the 3month and 6month the position of the macd?Mine shows we are at an interesting low area. Still think if we stay above. 0285 approximately we may never look back.
Those who think charting and otc dont go together, most of the time they dont, sometimes they do.
Imo.